OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Innate immune signaling in the ventral tegmental area contributes to drug-primed reinstatement of cocaine seeking
Kyle T. Brown, S Levis, Casey E. O’Neill, et al.
Brain Behavior and Immunity (2017) Vol. 67, pp. 130-138
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Neuroimmune signaling in alcohol use disorder
Emma K. Erickson, Emily K. Grantham, Anna S. Warden, et al.
Pharmacology Biochemistry and Behavior (2018) Vol. 177, pp. 34-60
Open Access | Times Cited: 189

Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway
Masaru Tanaka, Fanni Tóth, Helga Polyák, et al.
Biomedicines (2021) Vol. 9, Iss. 7, pp. 734-734
Open Access | Times Cited: 179

Microglia in neuroimmunopharmacology and drug addiction
Hongyuan Li, Linda R. Watkins, Xiaohui Wang
Molecular Psychiatry (2024) Vol. 29, Iss. 6, pp. 1912-1924
Closed Access | Times Cited: 17

Neuroimmune mechanisms of psychostimulant and opioid use disorders
Rebecca S. Hofford, Scott J. Russo, Drew D. Kiraly
European Journal of Neuroscience (2018) Vol. 50, Iss. 3, pp. 2562-2573
Open Access | Times Cited: 86

Oxidative Stress and Neuroinflammation as a Pivot in Drug Abuse. A Focus on the Therapeutic Potential of Antioxidant and Anti-Inflammatory Agents and Biomolecules
Pablo Berríos‐Cárcamo, Mauricio Quezada, Marı́a Elena Quintanilla, et al.
Antioxidants (2020) Vol. 9, Iss. 9, pp. 830-830
Open Access | Times Cited: 72

Neuroimmune Mechanisms as Novel Treatment Targets for Substance Use Disorders and Associated Comorbidities
Mark D. Namba, Jonna M. Leyrer‐Jackson, Erin K. Nagy, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 58

Impact of neuroimmune activation induced by alcohol or drug abuse on adolescent brain development
Consuelo Guerri, María Pascual
International Journal of Developmental Neuroscience (2018) Vol. 77, Iss. 1, pp. 89-98
Closed Access | Times Cited: 74

Drug addiction: a curable mental disorder?
Jianfeng Liu, Jun‐Xu Li
Acta Pharmacologica Sinica (2018) Vol. 39, Iss. 12, pp. 1823-1829
Open Access | Times Cited: 71

Cannabidiol Treatment Might Promote Resilience to Cocaine and Methamphetamine Use Disorders: A Review of Possible Mechanisms
Claudia Calpe-López, Maria Pilar García-Pardo, M.A. Aguilar
Molecules (2019) Vol. 24, Iss. 14, pp. 2583-2583
Open Access | Times Cited: 70

Microglia and BDNF at the crossroads of stressor related disorders: Towards a unique trophic phenotype
Natalie Prowse, Shawn Hayley
Neuroscience & Biobehavioral Reviews (2021) Vol. 131, pp. 135-163
Open Access | Times Cited: 48

Circuit selectivity in drug versus natural reward seeking behaviors
Rusty W. Nall, Jasper A. Heinsbroek, Todd B. Nentwig, et al.
Journal of Neurochemistry (2021) Vol. 157, Iss. 5, pp. 1450-1472
Open Access | Times Cited: 45

TLR4 biased small molecule modulators
Cong Lin, Hongshuang Wang, Miyuan Zhang, et al.
Pharmacology & Therapeutics (2021) Vol. 228, pp. 107918-107918
Closed Access | Times Cited: 44

Crosstalk between Mu-Opioid receptors and neuroinflammation: Consequences for drug addiction and pain
Javier Cuitavi, Jose Vicente Torres‐Perez, Jesús Lorente, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 145, pp. 105011-105011
Open Access | Times Cited: 32

Glial mechanisms underlying substance use disorders
Kay E. Linker, Sarah J. Cross, F.M. Leslie
European Journal of Neuroscience (2018) Vol. 50, Iss. 3, pp. 2574-2589
Open Access | Times Cited: 57

Does Traumatic Brain Injury Cause Risky Substance Use or Substance Use Disorder?
Christopher M. Olsen, John D. Corrigan
Biological Psychiatry (2021) Vol. 91, Iss. 5, pp. 421-437
Open Access | Times Cited: 35

Dopamine activates NF-κB and primes the NLRP3 inflammasome in primary human macrophages
Rachel Nolan, Katelyn Reeb, Yongzhang Rong, et al.
Brain Behavior & Immunity - Health (2019) Vol. 2, pp. 100030-100030
Open Access | Times Cited: 38

Transcriptional and epigenetic regulation of microglia in substance use disorders
Samara J. Vilca, Alexander V. Margetts, Tate A. Pollock, et al.
Molecular and Cellular Neuroscience (2023) Vol. 125, pp. 103838-103838
Open Access | Times Cited: 11

Cannabidiol Analogue CIAC001 for the Treatment of Morphine-Induced Addiction by Targeting PKM2
Sha Jin, Cong Lin, Yibo Wang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 16, pp. 11498-11516
Closed Access | Times Cited: 11

Toll-Like Receptor 4 Signaling and Drug Addiction
Ruyan Wu, Jun‐Xu Li
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 30

Inhibition of CSF1R, a receptor involved in microglia viability, alters behavioral and molecular changes induced by cocaine
Maria Carolina Machado da Silva, Giovanni Freitas Gomes, Heliana de Barros Fernandes, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 27

Contributions of neuroimmune and gut-brain signaling to vulnerability of developing substance use disorders
Kelsey E. Lucerne, Aya Osman, Katherine Meckel, et al.
Neuropharmacology (2021) Vol. 192, pp. 108598-108598
Open Access | Times Cited: 26

The impact of psychostimulants on central and peripheral neuro-immune regulation: a scoping review of cytokine profiles and their implications for addiction
Joana Bravo, Catarina Magalhães, Elva Bonifácio Andrade, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 10

Page 1 - Next Page

Scroll to top